English | Español

Technology/Innovation
+ Technology/Innovation
Patient Daily Report | Apr 24, 2023

Study on mice 'presents a potential pathway' for reversing or preventing graying of human hair
+ Technology/Innovation
Patient Daily | Apr 24, 2023

H1.co Named 2023 Website of the Year by the Health and IT Marketing Community
+ Technology/Innovation
Patient Daily | Apr 24, 2023

The University of Maryland Medical Center Chooses SOPHiA GENETICS Technology
+ Technology/Innovation
Patient Daily | Apr 24, 2023

Alliance between Telstar and Picarro
+ Technology/Innovation
Patient Daily | Apr 24, 2023

Telstar DiSQ, Digital Smart Qualification
+ Community
Patient Daily | Apr 24, 2023

Protect Yourself and Your Loved Ones by Properly Disposing Unused Medication
+ Community
Patient Daily | Apr 24, 2023

Zynex, Inc. to Announce First Quarter 2023 Financial Results
+ Community
Patient Daily | Apr 24, 2023

Weave Communications, Inc. Announces Date of First Quarter 2023 Financial Results and Conference Call

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation